This week the doctor discuss the irrefutable science for Ivermectin in the newly published scientific paper.

Authors: Bryant A, Lawrie TA, Dowswell T, Fordham E, Mitchell S, Hill SR et al. PMID: 34145166 PMCID: PMC8248252 DOI: 10.1097/MJT.0000000000001402 Abstract Background: Repurposed medicines may have a role against the SARS-CoV-2 virus. The antiparasitic ivermectin, with antiviral and anti-inflammatory properties, has now been tested in numerous clinical trials. Areas of uncertainty: We assessed the [...]

Authors: Niaee MS, Gheibl N, Namdar P, Allami A, Javadi A. DOI: 10.4103/1995-7645.318304 Abstract Permissions ORIGINAL ARTICLE Ivermectin as an adjunct treatment for hospitalized adult COVID-19 patients A randomized multi-center clinical trial Niaee, Morteza Shakhsi1; Namdar, Peyman2; Allami, Abbas3; Zolghadr, Leila4; Javadi, Amir5; Karampour, Amin3; Varnaseri, Mehran6; Bijani, Behzad7; Cheraghi, Fatemeh1; Naderi, Yazdan8; Amini, Fatemeh9; [...]

Dr. Kory joins Bret Weinstein, host of The DarkHorse Podcast to discuss “Covid, Ivermectin and the Crime of the Century.” This program, which many quickly called “the best podcast I have ever listened to” lays out the truth about ivermectin and how the suppression of its efficacy against COVID-19 has cost hundreds of thousands of people their lives.

Awareness of ivermectin’s efficacy and its adoption by physicians worldwide to successfully treat COVID-19 have grown exponentially over the past several months.

A global panel providing legal, ethical, clinical and political perspectives on the failure of public health organizations to recommend the worldwide use of ivermectin – a scientifically proven medicine to prevent and treat COVlD-19.

Authors: Mahmud R, Rahman M, Alam I, Ahmed KG, Kabir H, Sayeed SK et al. PMID: 33983065 PMCID: PMC8127799 DOI: 10.1177/03000605211013550 Abstract Objective: We evaluated whether ivermectin combined with doxycycline reduced the clinical recovery time in adults with COVID-19 infection. Methods: This was a randomized, blinded, placebo-controlled trial in patients with mild-to-moderate COVID-19 symptoms randomly [...]

We commend the tremendous efforts of the Indian central government, state governments, media personnel, doctors, nursing staff, police personnel, paramedical staff and other organisations in mitigating the suffering of Indians at this time.

Authors: Chamie-Quintero JJ, Hibberd JA, Scheim DE doi: https://doi.org/10.5061/dryad.dv41ns1xr Abstract Objective. We aimed to identify mortality trends associated with COVID-19 deaths in Peru during April through November 2020, when mass treatments with ivermectin (IVM), a drug of Nobel Prize-honored distinction, were autonomously deployed at different times and to different extents in [...]

Authors: Kory P, Meduri GU, Iglesias J, Varon J, Berkowitz K, Wagshul F et al. PMID: 34375047 doi: 10.1097/MJT.0000000000001377 PMCID: PMC8088823 Abstract Background: After COVID-19 emerged on U.S shores, providers began reviewing the emerging basic science, translational, and clinical data to identify potentially effective treatment options. In addition, a multitude of both novel and repurposed [...]